Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paclitaxel for Refractory/Relapsed Acute Leukemia and CML Blast Crisis
NCT00003230Phase 2Completed
- Sponsor
- Swiss Group for Clinical Cancer Research
- Start
- Jan 1998
- Primary completion
- Jul 2000
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of paclitaxel in acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), chronic myeloid leukemia (CML), sponsored by Swiss Group for Clinical Cancer Research. Started Jan 1998; status: completed.
02
Drugs
paclitaxel
03
Conditions
acute myeloid leukemia (AML)acute lymphoblastic leukemia (ALL)chronic myeloid leukemia (CML)
Beyond the preview
Go deeper on NCT00003230.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003230.